Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site  by Degtiar, V.E. et al.
Biophysical Journal Volume 73 July 1997 157-167
Calcium Channel Block by (-)Devapamil Is Affected by the Sequence
Environment and Composition of the Phenylalkylamine Receptor Site
V. E. Degtiar,* S. Acz6l,* F. Doring,* E. N. Timin,# S. Berjukow,* D. Kimball,§ J. Mitterdorfer,* and S. Hering*
*Institut fur Biochemische Pharmakologie, A-6020 Innsbruck, Austria; #A. V. Vishnevsky Institute of Surgery, 113 039 Moscow, Russia;
and 5Bristol-Myers Squibb Pharmaceutical Company, Princeton, New Jersey 08543-4000 USA
ABSTRACT The pore-forming a1 subunit of L-type calcium (Ca2+) channels is the molecular target of Ca2+ channel blockers
such as phenylalkylamines (PAAs). Association and dissociation rates of (-)devapamil were compared for a highly PAA-
sensitive L-type Ca2+ channel chimera (Lh) and various class A Ca2+ channel mutants. These mutants carry the high-affinity
determinants of the PAA receptor site in a class A sequence environment. Apparent drug association and dissociation rate
constants were significantly affected by the sequence environment (class A or L-type) of the PAA receptor site. Single point
mutations affecting the high-affinity determinants in segments IVS6 of the PAA receptor site, introduced into a class A
environment, reduced the apparent drug association rates. Mutation 11811 M in transmembrane segment IVS6 (mutant
AL25/-l) had the highest impact and decreased the apparent association rate for (-)devapamil by -30-fold, suggesting that
this pore-lining isoleucine in transmembrane segment IVS6 plays a key role in the formation of the PAA receptor site. In
contrast, apparent drug dissociation rates of Ca2+ channels in the resting state were almost unaffected by point mutations
of the PAA receptor site.
GLOSSARY
BN fraction of blocked channels after the Nth
pulse
B00 steady level of the current inhibition
(-)-dev (-)-devapamil
[D] drug concentration
gCa(t) fraction of open channels
gpeak, max maximum value of 9peak
IBa barium inward current through Ca2+ channels
It peak current values in drug at a given time
(t) after a train
'15 peak current values of the 15th conditioning
pulse
IO peak current values in absence of drug
iss steady (noninactivating) current component
'peak peak current value
k1 [D] apparent first-order association rate constant
k1 apparent second-order association rate
constant
k-I apparent dissociation rate constant
q-(-)dev q-(-) devapamil; quatemary derivative of
(-)devapamil
T period of stimulation
Greek symbols
Tblock time constant of peak current inhibition during
a train
Trec time constant of recovery from block at rest
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INTRODUCTION
The pore-forming a, subunit of L-type Ca2+ channels
(classes C(alc), D(alD), and S(aIs)) is the molecular target
of Ca2+ channel blockers such as phenylalkylamines
(PAAs). L-type Ca2+ channels have much higher affinity
for PAAs compared to other classes (A(al A), B(al1B), and
E(alE)) (Glossmann and Striessnig, 1990; Catterall and
Striessnig, 1992; Birnbaumer et al., 1994; Hofmann et al.,
1994; Catterall, 1995; Dunlap et al., 1995; Ishibashi et al.,
1995; Diochot et al., 1995). The action of PAAs on L-type
Ca2+ channels is crucially dependent on the open-channel
conformation (Lee and Tsien, 1983; McDonald et al., 1994;
Hering et al., 1989; Timin and Hering, 1992). A major step
toward an understanding of the molecular mechanism of
high-affinity PAA interaction with L-type Ca2+ channels
was made by Hockerman et al. (1995), who systematically
mutated transmembrane segment IVS6 of the alc subunit
and identified three putative pore-oriented amino acids
(Tyr-1463, Ala-1467, Ile-1470, numbering according to
a Ic-c; Hockerman et al., 1995) as molecular determinants of
the PAA receptor site. High PAA sensitivity can be gener-
ated for class A Ca2+ channels by transferring the IVS6
segment of L-type a Is to alA, accordingly (Doring et al.,
1996). Furthermore, we have recently demonstrated that
replacement of as few as three amino acids in transmem-
brane segment IVS6 of the alA subunit by the respective
L-type residues (11804Y, S1808A, and M18111, chimera
AL25; alA numbering) is sufficient to support use-depen-
dent block by (-)gallopamil. Transfer of only part of the
L-type PAA receptor site to alA induced a less pronounced
use-dependent Ca2+ channel block (Hering et al., 1996).
In the present paper we expressed the L-type Ca2+ chan-
nel construct Lh and various alA mutants containing either
the high-affinity PAA receptor site of L-type Ca2+ channels
in transmembrane segment IVS6 (mutant AL25; Hering et
al., 1996) or only part of it (mutants AL25/-Y, AL25/-A,
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AL25/-I) together with ,B. and a2-8 subunits in Xenopus
oocytes (Grabner et al., 1996). We performed a quantitative
analysis of the apparent PAA association and dissociation
rates of the PAA (-)devapamil by means of a previously
described technique (Timin and Hering, 1992). Our results
demonstrate that the apparent PAA-Ca2+ channel associa-
tion and dissociation rates are not only affected by single
point mutations of the putative PAA receptor site, but by its
sequence environment as well (alA or a1c).
The method for estimation of apparent association and dissociation rate
constants from the kinetics of use-dependent inhibition of Ca21 channels
was previously described in detail (Timin and Hering, 1992). Rate constant
k, describes drug association with open Ca2+ channels. We did not dis-
tinguish between drug dissociation from different channel states (open/
closed) and estimated a single dissociation time constant k_,I reflecting
drug dissociation from open as well as from closed channel states. Drug-
bound channels were postulated to be not conducting.
The kinetic equation (see also Starmer and Grant, 1985) is
dB
dt = kj[D] - gca(t) * (1- B) -k_ * B
MATERIALS AND METHODS
Electrophysiology
Inward barium currents were studied with two-microelectrode voltage-
clamp of Xenopus oocytes after microinjection of cRNAs (2-7 days) in
approximately equimolar mixtures of a, (0.3 ng/50 nl)/1,3a (16) (0.1 ng/50
nl)/a2-8 (17) (0.2 ng/50 nl) as previously described (Grabner et al., 1996;
Hering et al., 1996). All experiments were carried out at room temperature
in a bath solution with the following composition: 40 mM Ba(OH)2, 40
mM N-methyl-D-glucamine, 10 mM HEPES, 10 mM glucose (pH adjusted
to 7.4 with methanesulfonic acid). Voltage-recording and current injecting
microelectrodes were filled with 2.8 M CsCl, 0.2 M CsOH, 10 mM EGTA,
and 10 mM HEPES (pH 7.4) and had resistances of 0.3-2 Mfl. Activation
of endogenous Ca2+-activated Cl- conductance by barium influx through
Ca21 channels was eliminated by injecting the oocytes 20-40 min before
the voltage-clamp experiments with 50-100 nl of a 0.1 M 1,2-bis(2-
aminophenoxy)ethane-N,N,N,N-tetraacetic acid solution. Peak IBa ampli-
tudes of the expressed channel constructs ranged from 200 to more than 5
,uA. Oocytes with current amplitudes that were larger than 2 ,uA were
excluded from the analysis.
The recording chamber (150 ,ul total volume) was continuously per-
fused at a flow rate of 1 m/min with control or drug-containing solutions.
Data were digitized at 2 kHz, filtered at 0.5 kHz, and stored on a computer
hard disk. We used the pClamp software package (version 6.0; Axon
Instruments) for data acquisition and analysis. Leakage current correction
was performed by using average values of scaled leakage currents elicited
by a 10-mV hyperpolarizing voltage step.
where B equals the fraction of blocked channels, gca(t) the fraction of open
channels, [D] the concentration of drug, and k, and k_ the apparent
association and dissociation rate constants, respectively. The solution of
the above equation predicts an exponential increase in the fraction of
blocked channels during a train:
BN = B,jj - o-N(T)]
where BN is the fraction of blocked channels after the Nth pulse, B,,O is the
steady level of the current blockade, and T is the period of stimulation. The
parameters of the current blockade in a train (a and B,,,) were determined
from experimental data by a least-squares analysis. The solution of the
kinetic equation links the parameters of the blockade in train with the
apparent first-order rate constants k1 [D] and k_ 1.
kD] ln(I + (DL(T))k1[D] = ftlDW gCa(t)dt
k_ = -ln{oa(T)[1 + (D(T)]}/T
where
,,(T) = BX[1 a-(T)]o-c(T)
Intracellular application of (-)q-devapamil
The intracellular action of the quatemary derivative of (-)devapamil,
(-)q-devapamil, was studied by microinjecting 50 nl of a 1 mM solution
of (-)q-devapamil (dissolved in distilled water) into oocytes expressing
chimeras Lh and AL25. Assuming an average oocyte volume of 0.5 ,ul, we
calculated an intracellular concentration of 100 ,uM.
Estimation of association and dissociation rate
constants to open Ca2+ channels
Use-dependent block of IBa by (-)devapamil was studied during 15
subsequent test pulses of different lengths applied at a standard frequency
of 0.1 Hz from -80 mV holding potential to a test potential of 20 mV. The
oocytes were held for 15-25 min (depending on the batch of oocytes) at
-80 mV until IBa was stable. IBa of class A mutants were stable under
voltage-clamp conditions up to 3 h; IBa "run-down" was negligable. To
evaluate the peak IBa decay under control conditions, we applied identical
test pulse sequences in the absence of drug. PAA effects on IB. were
studied after a 3-min equilibrium period in drug-containing solution. Tonic
("resting-state dependent") block after a 3-min equilibration in 50 p.M
(-)devapamil containing solution was usually less than 10% (Hering et al.,
1996).
An appropriate software (USE-DEP) was developed. The following values
were utilized for estimation of the apparent rate constants: 1) peak current
values, 2) individual current time integrals of a given train (15 pulses), and
3) period of pulse application. Current traces were processed by means of
the software pCLAMP (Axon Instruments), thereby creating files for the
USE-DEP software. The statistical significance of IBa block by (-)deva-
pamil was calculated according to an unpaired Student's t-test. Data are
given as mean ± SD.
Molecular biology
The construction of chimera Lh (repeats I-IV from alc-a; Mikami et al.,
1989), N-terminus replaced by the corresponding sequences from carp
skeletal muscle a,s (Grabner et al., 1991), was previously described
(Doring et al., 1996; Grabner et al., 1996; Hering et al., 1996). Chimera
AL25 and its derivatives AL25/-Y, AL25/-A, and AL25/-I (Hering et al.,
1996) were constructed by introducing point mutations into aIA cDNA
(Mori et al., 1991) by the "gene SOEing" technique (Horton et al., 1989).
AL30 was generated by applying the same procedure to introduce five
point mutations (Y13861, M1387F, A1390S, I1393M, 11394L; amino acid
numbering according to carp skeletal muscle aIs; Grabner et al., 1991) into
chimera AL23. Construction of AL23 was described in detail (Doring et
al., 1996). Polymerase chain reaction (PCR) was performed using proof-
reading Pfu-polymerase (Stratagene), and fused SOE-cDNAs were inserted
into the KpnI (nucleotide 5467)-BglII (nucleotide 6185) cassette of chimera
158 Biophysical Journal
Ca2+ Channel Block by Phenylalkylamines
AL22 (Doring et al., 1996). Chimeric constructs were verified by sequence
analysis (Sanger et al., 1977).
RESULTS
Apparent association and dissociation rates of
(-)devapamil for the L-type chimera Lh and the
PAA-sensitive class A Ca2+ channel mutant AL25
To evaluate the influence of the sequence environment of
the PAA receptor on the kinetics of Ca2+ channel block, we
expressed chimeras Lh (Grabner et al., 1996) and the class
A Ca2+ channel mutant AL25 (Hering et al., 1996) in
Xenopus oocytes. Mutant AL25 was constructed by trans-
ferring the putative high-affinity determinants of the L-type
PAA receptor site (Hockerman et al., 1995) to transmem-
brane segment IVS6 of alA (mutations I1804Y, S1808A,
and M18111; Hering et al., 1996).
Fig. 1 displays current traces of chimeras Lh and AL25
evoked by pulses from a holding potential of -80 mV to a
test potential of 20 mV in the presence of 50 ,uM (-)deva-
pamil. Prolongation of the test pulse accelerated the block
development and induced a more pronounced current inhi-
bition in steady state. The current inhibition at a given pulse
length (50, 100, or 800 ms) developed faster in chimera
AL25 (Fig. 1). A comparison of the first-order apparent rate
constants (k1[D], k-1) of mutant AL25 and chimera Lh is
given in Table 1. Compared to chimera Lh, the apparent
drug association and dissociation rates were significantly
higher in mutant AL25. Prolongation of the test pulse from
50 to 800 ms (Table 1) did not significantly affect the
apparent drug association rate, although the main charac-
teristics of the current inhibition (time constant of peak
current decay, steady-state level of block) differed notably
for both channel constructs (Fig. 1). As expected, associa-
tion but not drug dissociation rate was dependent on the
applied drug concentration (Table 2).
Drug dissociation from chimera Lh and mutant
AL25 in the resting state
The dissociation rate of (-)devapamil with resting Ca2+
channels can be estimated by studying the recovery of Ca2+
channels from use-dependent block by applying an addi-
tional test pulse after different time intervals after the con-
ditioning pulse train. The estimation of PAA dissociation
rates from resting Ca2+ channels at a holding potential of
-80 mV is illustrated in Fig. 2. Between subsequently
applied trains, the membrane was held for 3 min at -100
mV to remove block by (-)devapamil (Fig. 2). IBa of AL25
recovered at a holding potential of -80 mV from block
within -4 min, whereas IBa of L-type chimera Lh at the
same potential did not completely recover, even within 8
min, indicating that the estimated recovery time constant
(Fig. 2 and Table 2) reflects only the fast kinetic component
of drug dissociation at this potential. We were, however,
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FIGURE 1 Use-dependent IBa block by (-)devapamil during trains of
test pulses in oocytes expressing chimera Lh and mutant AL25. (A) Peak
IBa amplitudes of Lb during 15 consecutive depolarizing voltage pulses
applied from the holding potential of -80 to 20 mV at 0.1 Hz in the
presence of 50 ,uM (-)devapamil. The pulse durations were 50 ms (-),
100 ms (-), and 800 ms (-). IBa amplitudes were normalized to the
amplitude of IBa elicited by the first pulse in a train. Corresponding IBa
recordings are shown in the top of the panel. (B) Use-dependent peak IBa
decay in the presence of 50 ,uM (-)devapamil of mutant AL25. Pulse
protocol and symbols are the same as in A. Data were fitted by single-
exponential functions I - (1 - ISS)exp(-t/Tblock), yielding the following
steady-state levels and time constants (VssTblock (s)): Lh: *, 0.72 and 62 s;
*, 0.62 and 46 s; A, 0.4 and 14 s; AL25: *, 0, 59, and 21 s; E, 0.54 and
14 s; A, 0.48 and 5 s.
unable to resolve the kinetics of the slow component of IBa
recovery from block in Lh, because a contamination by
current rundown during longer lasting measurements could
not be excluded. Complete unblock of Lh was, however,
achieved at more negative holding potentials (-100 to
-120 mV), indicating a voltage dependence of drug disso-
ciation (data not shown).
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TABLE 1 Apparent first-order association (k1[DJ) and dissociation (k-1) rate constants of (-)devapamil (50 1,M) interaction with
chimera Lh and mutant AL25 estimated for different test pulse length
Test pulse Lh AL25
length
(ms) k,[D] (s ') k (s-') k,[D] (s-') k_, (s-
20 6.5 ± 1.56 (n = 3) 0.023 ± 0.0017 (n = 3)
50 1.62 ± 0.55 (n = 4) 0.013 ± 0.0013 (n = 4) 6.3 ± 1.56 (n = 3) 0.025 + 0.0005 (n = 3)
100 1.1 ± 0.4(n = 4) 0.012 ± 0.006(n = 4)* 6.2 ± I (n = 4) 0.026 ± 0.002(n = 4)*
200 6.5 ± 1.73 (n = 3) 0.029 ± 0.0017 (n = 3)
400 4.6 ± 2.2 (n = 3) 0.030 ± 0.0008 (n = 3)
800 1.0 ± 0.3 (n = 4) 0.017 ± 0.006 (n = 4)* 5.6 ± I (n = 4) 0.031 + 0.004 (n = 4)*
*Significantly different for experiments performed with 100-ms and 800-ms long test pulses (p < 0.05). Conditioned block of IBa was measured during
trains of 15 consecutive depolarizing voltage pulses (100 ms, 0.1 Hz). Values are given as mean ± SD (n, number of experiments).
Molecular determinants of the PAA receptor site
in transmembrane segment IVS6 affect apparent
association rate for (-)devapamil
Three amino acids form the putative high-affinity binding
site for PAAs in L-type Ca2+ channels (Hockerman et al.,
1995). If only two out of three amino acids are transferred
from als to al1A the sensitivity of the resulting mutants for
the PAA (-)gallopamil is significantly reduced (Hering et
al., 1996). We made a similar observation for the block of
aIA-derived Ca2+ channel mutants by (-)devapamil. Com-
pared to chimera AL25 that carried three high-affinity de-
terminants of the PAA receptor site, the steady level of
block by (-)devapamil was reduced when one of the high-
affinity determinants was replaced by the corresponding
amino acid of the alA subunit (Tyr replaced by Ile in
AL25/-Y, Ala by Ser in AL25/-A, and Ile by Met in
AL25/-I) (see Table 3). The kinetics of IBa block by 50 ,uM
(-)devapamil during a 0.1-Hz pulse train (100 ms) of
mutants AL25, AL25/-Y, AL25/-A, and AL25/-I are com-
pared in Fig. 3 A and B. As expected, the fastest develop-
ment of block was observed for mutant AL25 carrying all
three amino acids of the putative PAA receptor site. Sub-
stitutions Y1804I and A1808S, yielding mutants AL25/-Y
and AL25/-A, respectively, slowed the kinetics of block
development and additionally exhibited a reduced steady
level of block (Table 3). The most dramatic reduction in
block development occurred after substitution of 11811M in
AL25, resulting in mutant AL25/-I. The corresponding ap-
TABLE 2 Concentration dependence of apparent first-order
association (k,[DJ) and dissociation (k-4) rate constants of
(-)devapamil (Dev) with chimera Lh and mutant AL25
[Dev] Lh AL25
5 j.LM k1[D](s-') 0.3 ± 0.16 (n = 7) 1.4 ± 0.55 (n = 18)*
50 AM k,[D](s-') 1.1 ± 0.38 (n = 10) 5.5 ± 1.45 (n = 25)*
5 ,uM k ,(s-') 0.012 ± 0.008 (n = 7) 0.026 ± 0.0085 (n = 18)*
50 ,AM k-,(s-1) 0.015 ± 0.0064 (n = 10) 0.032 ± 0.03 (n = 25)*
50 ,M Tree(S) 106 ±22 (n = 4) 67 ± 12.1 (n = 3)
Values are given as mean ± SD (n, number of experiments).
*Values for Lh and AL25 differ significantly (p < 0.05).
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FIGURE 2 Recovery of IBa from block induced by 15 subsequently
applied pulses from -80 mV to 20 mV in the presence of 50 ,uM
(-)devapamil in oocytes expressing chimera Lh and mutant AL25. To
increase the amount of peak IBa inhibition during the conditioning train, the
pulse length during IBa measurements of Lh was extended to 800 ms.
Recovery reflects mainly channel unblock, because less than 5% (n = 5)
of the peak IBa of Lh and 12 ± 5% (n = 4) of AL25 accumulated in an
inactivated state during the pulse train in control. (Upper panels) IB.
records illustrating current recovery from block. Superimposed traces of
IBa during trains (100 ms, 0.2 Hz for AL25, or 800 ms, 0.1 Hz for Lh) and
single traces recorded at different times after a train are displayed. (Lower
panel) Normalized peak IBa corresponding to currents shown in the upper
panel. The applied pulse protocol is displayed in the inset. Extent of
recovery from block was calculated as Recovery = (I - I15)(IO -I5),
where I, is the peak current value in drug at a given time (t) after a train,
I,5 is the peak current value of the 15th conditioning pulse (maximum
block); Io is the peak current value in absence of drug. Curves represent
single-exponential fits (Recovery = C * { 1- exp(-(t/Trec)}). Parameters
of fit (AL25, 0): C = 1, Tre = 73 S; Lh, *: C = 0.76, Tr, = 96 s. Between
the subsequently applied pulse trains the membrane voltage was held for 3
min at -100 mV, resulting in complete unblock of the channels. IBa of
mutant AL25 recovered by up to 100% of its initial value, whereas
recovery of chimera Lh at the same holding potential was incomplete
(range 0.60-0.85). Prolonged hyperpolarization at -100 mV consistently
induced 100% recovery from use-dependent block of Lh.
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TABLE 3 Use-dependent inhibition Of /Ba by (-)devapamil in mutants AL25, AL25/-Y, AL25/-A, and AL25/-I and apparent
dissociation rate constants
Peak current inhibition
AL25 AL25/-Y AL25/-A AL25/-I
Contr. 8 +3.1% (n = 15) 9.3 ± 0.6% (n = 3) 7.2 + 3.6% (n = 5) 4.5 2 (n = 4)
Dev 5 ,tM 24 7.2% (n = 13) 10.6 ± 1.6% (n = 3) 12 ± 5.2% (n = 3) 5.6 2.9% (n = 3)
50 ,uM 49 12% (n 16) 22 ± 10% (n 4)* 20 ± 6% (n = 4)* 9.7 +7.4% (n = 5)*
500 ,uM 77 5.2% (n 3) 46 ± 7.3% (n =6)* 60 ± 7% (n = 3) 22 4.8% (n = 3)*
k- (s )
Dev 50 ,uM 0.033 + 0.0032 (n = 29) 0.032 ± 0.003 (n - 3) 0.031 ± 0.01 (n = 6) 0.044 + 0.022 (n = 5)
500 AM 0.027 ± 0.009 (n = 3) 0.035 ± 0.01 (n = 6) 0.025 ± 0.005 (n = 3) 0.02 + 0.005 (n = 3)
Trec (S)
500 ,uM 69 + 16(n = 3) 66 ± 22(n = 3) 75 ± 20(n = 4) 76 12(n = 3)
Conditioned block of IBa by (-)devapamil (5 ,uM, 50 ,uM, and 500 ,tM) was measured during trains of 15 consecutive depolarizing voltage pulses (100
ms, 0.1 Hz). Values are given as mean +SD (n, number of experiments).
*Significant differences in current inhibition compared to the mutant channel AL25 (p < 0.05).
parent drug association rate constants for different (-)deva-
pamil concentrations are shown in Fig. 3 C. Linear regres-
sion of the concentration-dependent first-order association
rate yielded second-order association rate constants for the
A
channel mutants. Mutant AL25, carrying three amino acids
of the putative PAA receptor site, displayed the highest
sensitivity to (-)devapamil (KI = 1.1 X 105 M-1 S-1),
whereas the single amino acid substitutions Y18041 (AL25/-Y,
B
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* AL25
~/1100e
FIGURE 3 IBa block by (-)deva-
pamil in mutants AL25, AL25/-Y,
AL25/-A, and AL25/-I. (A) 'Ba were
elicited by 100-ms pulse trains from
-80 mV to 20 mV (0.1 Hz) in the
absence and presence of 50 ,uM
(-)devapamil. High-affinity deter-
minant amino acids of the L-type
PAA receptor site transferred to the
class A Ca2+ channel are schemati-
cally indicated in single-letter code
(Y, A, I) as filled circles; correspond-
ing class A amino acids are repre-
sented by white circles. (B) Time
courses of peak current inhibition
(same experiments as shown in A) of
AL25 (0), AL25/-Y (0), AL25/-A
(L), and AL25/-I (A) with estimated
apparent drug association and disso-
ciation rate constants (in s- 1). (C)
Apparent association rate constants at
different (-)devapamil concentra-
tions fitted by a linear regression. Es-
timated second-order association
rates (in M-l s- ) are indicated.
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K, = 3.4 X 104 M-] s-') and A1808S (AL25/-A, K1 =
3.6 X 104 M-1 s-1) decreased the apparent drug association
rate about threefold. Substitution I1811M (AL25/-I, K1 =
3.1 X 10 3 M -1 s -') induced a 30-fold decrease in the
apparent PAA association rates.
Enhanced Ca2+ channel inactivation does not
promote PAA sensitivity of class A/L-type
chimeras lacking the high-affinity PAA
determinants in IVS6
In a previous study we have shown that transfer of the three
high-affinity PAA determinants (Hockerman et al., 1995)
from L-type al to the P/Q-type alA subunit enhances not
only PAA sensitivity, but induces a substantial acceleration
in IBa inactivation of the resulting mutants (Hering et al.,
1996). Transfer of an additional L-type residue to segment
IVS6 of alA (mutation F1805M; Hering et al., 1996) again
attenuated both PAA sensitivity and current inactivation
kinetics of the resulting quadruple mutant AL25/M (Hering
et al., 1996). Furthermore, as shown in Fig. 3 A, the most
remarkable reduction in PAA sensitivity was observed in mu-
tant AL25/-I, displaying the slowest inactivation time course.
To test if Ca2+ channel inactivation determines the PAA
sensitivity of alA in a manner that is independent of a
high-affinity interaction with its receptor site, we designed
mutant AL30, which does not carry the high-affinity PAA
determinants (see Materials and Methods) but inactivates at
a significantly faster rate than the wild-type alA. As shown
in Fig. 4, despite its significantly faster inactivation kinetics,
PAA sensitivity of AL30 (estimated as use-dependent block
by 50 ,uM D888) was comparable to the sensitivity of the
low sensitive alA subunit (see also Doring et al., 1996).
However, a direct comparison of the rapidly inactivating
AL30 with the highly PAA-sensitive chimeras AL25,
AL25/M, and AL25/-Y, M (Hering et al., 1996) reveals that
accelerated current inactivation per se does not introduce a
higher PAA sensitivity into the alA subunit (Fig. 4).
Different affinities of AL25, AL25/-Y, AL25/-A, and
AL25/-I for (-)devapamil were also evident from different
drug-induced open-channel block, resulting in an accelera-
tion of current decay (Fig. 5). Whereas high concentrations
of (-)devapamil (500 ,uM) caused a prominent acceleration
in IBa decay in AL25 and AL25/-A, effects on IBa of
AL25/-Y and AL25/-I were small or hardly detectable (Fig. 5).
Molecular determinants of the PAA receptor site
in transmembrane segment IVS6 do not affect
the apparent dissociation rate constants
As shown in Table 3, apparent (-)devapamil dissociation
rates were not significantly affected by point mutations of
FIGURE 4 Ca2+channel inactiva-
tion does not promote the PAA sen-
sitivity of class AAL-type chimeras
lacking the high-affinity PAA deter-
minants in segment IVS6. (A, B) IBa
of mutants AL25 (A) and AL30 (B)
during a 0.1-Hz pulse train in con-
trols and in the presence of 50 ,uM
(-)devapamil. Note the faster inacti-
vation time course of AL30 com-
pared to AL25 shown in A. (C) Com-
parison of IBa inactivation of chimera
AL30 with wild-type class A (alA),
AL25, AL25/-Y, AL25/-A, and
AL25/-I (data for ClA, AL25, AL25/
-Y, AL25/-A, and AL25/-I are from
Hering et al., 1996), measured as IBa
decay during a 100-ms test pulse
from -80 mV to 20 mV. Statistical
significant acceleration of current in-
activation compared to class A chan-
nel IBa (p < 0.01) is indicated by
asterisks (n = 4-9). (D) Use-depen-
dent peak IBa inhibition of AL30 by
50 ,uM (-)devapamil (grey columns)
and AL25 (black columns) during 15
depolarizing pulses from -80 mV to
20 mV (mean + SEM, n = 3) com-
pared to current inhibition in the ab-
sence of drug (control). Statistical
significance of IBa block compared to
control (p < 0.01) is indicated by
asterisks.
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FIGURE 5 Acceleration of IBa de-
cay by (-)devapamil. (A) Current
traces (mutants AL25, AL25/-Y,
AL25/-A, AL25/-I) during depolar-
izations from -80 to 20 mV in con-
trols and after cumulative application
of 50 t,M and 500 ,uM (-)deva-
pamil. IBa were scaled to display
drug-induced changes in current de-
cay. (B) The mean values of IBa de-
cay rate (kdecay) in control and drug,
determined by means of monoexpo-
nential fit of the descending phases of
JBa: IBa, decay = A * exp(-t * kdecay)
during a 100-ms pulse.
the putative PAA receptor site, as would be expected from
alterations in the amino acid composition of the binding
domain. This striking result prompted us to examine the
recovery of resting Ca2+ channels from block at -80 mV
by measuring peak currents at different intervals after a
conditioning pulse train. A high concentration of (-)deva-
pamil (500 ,uM) was applied to induce substantial channel
block in the mutants AL25/-Y, AL25/-A, and AL25/-I,
which display a reduced PAA sensitivity compared to
AL25. The time course of IBa recovery from use-dependent
block by 500 ,uM (-)devapamil and corresponding current
traces of mutants are illustrated in Fig. 6 (pulse protocol as
in Fig. 2). Like the (-)devapamil dissociation rate constant,
the recovery time constants from block at rest were not
significantly affected by the removal of single L-type amino
acid determinants of the PAA receptor site (Table 3).
Amino acids crucial for PAA action are
pore orientated
The estimation of apparent drug association and dissocia-
tion rate constants is based on the assumption that PAAs
interact with a receptor site that is located within the chan-
nel pore and is accessible only via the open Ca2+ channel
conformation. During the present study we obtained inde-
pendent lines of evidence confirming a high-affinity inter-
action of (-)devapamil with putatively pore-oriented amino
acids of chimera Lh and the alA triple mutant AL25.
First, the permanently charged quatemary (-)devapamil
derivative (-)q-devapamil induced use-dependent IBa inhi-
bition. Because of its permanent charge, (-)q-devapamil is
expected to access its binding domain within the channel
pore exclusively via a hydrophilic pathway. As previously
shown for the quatemary gallopamil (D890) in wild-type
Ca2+ channels (Hescheler et al., 1982), (-)q-devapamil
efficiently blocked Ca2+ channels of Lh and AL25 when
applied to the intracellular side of the membrane. Fig. 7
shows 'Ba of Lh and AL25 during a train of 15 depolarizing
test pulses (100 ms, 0.1 Hz) applied 5 min after microin-
jection of 50 nl (-)q-devapamil (1 mM) into the cytoplasm
of a Xenopus oocyte (corresponding to an intracellular con-
centration of -100 ,uM; see Materials and Methods), com-
pared to currents measured by the same pulse protocol in an
oocyte of the same batch in drug-free solution. When 100
,uM (-)q-devapamil was applied to the extracellular site,
the same pulse protocol induced only weak IBa block in Lh
and AL25 (Fig. 7). The amount of IBa inhibition during a
pulse train by intracellularly applied (-)q-devapamil was
comparable to use-dependent block by tertiary (-)deva-
pamil (compare traces in Fig. 7 with cumulative current
inhibition in the presence of 50 ,uM (-)devapamil in
Fig. 1).
Second, IBa inactivation was not a precondition for chan-
nel block by (-)devapamil. This could be clearly demon-
strated for mutant AL25, where long-lasting depolarizations
of the membrane in the presence of 50 ,uM (-)devapamil
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A B
FIGURE 6 Recovery of IBa from
use-dependent block by (-)deva-
pamil in mutants AL25/-Y, AL25/-A,
and AL25/-I. The same pulse proto-
col as shown in Fig. 2 was used. (A)
Current traces illustrating the recov-
ery from block for the indicated mu-
tant class A Ca21 channels at a hold-
ing potential of -80 mV. (B) Time
course of peak current recovery of
the experiments shown in A. The re-
covery function was measured as
shown in Fig. 2. Curves represent
monoexponential fits for the exper-
imental points by the function
'Ba, recovery = 1 - exp(-t/Trc); re-
covery time constants are indicated.
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did not significantly (p > 0.05) affect the availability of
Ca2+ channels of AL25 (Vos5, control = -19 + 2 mV,
VO.5 drug = -20 ± 2 mV, n = 4, Fig. 8 A). We observed,
AL25
A
Control
V
qDev
(out)
400 nA
l oo ms
however, some changes in the voltage dependence of Ca2+
channel availability in similar experiments with Lh:
V0.5, control = -26 + 4 mV versus V.5, drg = - 34 + 6 mV,
Lh
BqDev
(in) Control
qDev
(in)
200 nA
400
FIGURE 7 Action of the permanently charged quarternary (-)devapamil derivative q-(-)devapamil on the IBa of chimera Lb and mutant AL25. (A) IBa
of AL25 elicited by 100-ms pulses applied at 0.1 Hz from -80 to 20 mV in controls and after extracellular (out, 50 ,uM) or intracellular (in, -100 ,uM;
see Materials and Methods) application of (-)q-devapamil. Control currents and currents measured during a train after extracellular application of
(-)q-devapamil are from a different oocyte than currents measured after microinjection of the drug. (B) IBa of chimera Lb elicited by a train of 800-ms
test pulses (0.1 Hz) from -80 to 20 mV in a control oocyte and after intracellular application of - 100 ,uM (-)q-devapamil. Extracellular application of
100 ,uM (-)q-devapamil did not induce significant peak current inhibition in Lh (data not shown).
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FIGURE 8 Availability (0, control; *, in 50 ,uM (-)devapamil) and
activation (0, control; *, in 50 ,uM (-)devapamil) curves of the mutant
AL25 (A) and chimera Lh (B). Activation was measured as m = gpeak/gpeak,
max, where gpeak =peak/(E - Erev). gpeak, max' maximum value of gPeak,
measured on the descending phase of the current-voltage relationship.
Availability (h) was estimated from normalized peak IBa during a 50-ms
test pulse after the 10-s conditioning prepulse of a given voltage. The
interpulse interval was 3 ms. Conditioning and test pulses were applied
every 60 s from a holding potential of -100 mV. Curves are drawn
according to the equation I"Imax = Is, + (1 -IS)(1 + exp[(V -V0.)k)]
ss control = 0.38 ± 0.05 versus Iss, control =0.05 ± 0.03,
kcontrol = 9.9 ± 0.8 mV versus kdrug = 8.6 ± 0.3 mV, n =
3 (p < 0.05) (Fig. 8 B). Neither the midpoint voltage IBa
activation of Lh (V0.5, control = -16.5 ± 7 mV versus
VO.5, drug = -16 + 5 mV) nor that of AL25 (V0.5, control =
10 ± 3 mV versus V05 drug = 7 + 2 mV, n = 3) was
significantly affected by 50 ,uM (-)D888.
In contrast to the high-affinity interaction of L-type Ca21
channels with antagonist 1,4-dihydropyridines (Bean,
1984), resulting in a pronounced shift in the midpoint volt-
age of the Ca2+ channel availability curve (Hering et al.,
1993), the PAA-induced shift was not significant for AL25
or for the L-type chimera Lh (p > 0.05). Our data confirm
that PAA-induced block does not occur at voltages below
the threshold of channel activation (see corresponding ac-
tivation curves in Fig. 8) and requires the open state (Lee
and Tsien, 1983; McDonald et al., 1984; Hering et al.,
1989). However, our results do not exclude the possibility
that channel inactivation that occurs after drug interaction
with its high-affinity receptor site could play a role in the
stabilization of a nonconducting channel conformation
(Nawrath and Wegener, 1997). The reduction of the "non-
inactivating" current component (IS) and changes in the
slope (k) of the fitted Boltzman function can hardly be
attributed to a shift and scaling of the availability curve, as
predicted for a high-affinity interaction of a drug with
closed inactivated Ca2+ channels. Drug-induced deviations
in the shape of the availability curve of Lh were correlated
with the activation curve (Fig. 8 B) and more likely result
from an open-state-dependent block than from (-)deva-
pamil interaction with inactivated channels (see Hering and
Timin, 1993, for detailed theoretical analysis).
DISCUSSION
Kinetics of state-dependent Ca2+ channel inhibition by
Ca2+ anatgonists (e.g., PAAs) during repeated depolariza-
tions can be characterized by the peak current inhibition
during a pulse train and the time constant of block devel-
opment. Both parameters are strongly dependent on the
experimental conditions, such as pulse length and frequency
of stimulation (see Fig. 1). These indices make it possible to
compare different drug affinities for a given channel popu-
lation if a standard pulse protocol is used. The availability of
cloned Ca2+ channels and the recent identification of the
high-affinity determinants of the PAA receptor site provide
the means for a detailed mutational analysis of PAA-Ca2+
channel interaction (Hockerman et al., 1995; Doring et al.,
1996; Hering et al., 1996). Swapping of sequences between
different channel types as well as single point mutations are
often accompanied by changes in current kinetics. Applied
pulse protocols have to be adapted for a given channel
construct, thereby complicating a direct comparison of drug
affinities in terms of the parameters mentioned above.
Therefore, we made use of a technique for estimation of
apparent association and dissociation rate constants that
does not depend on the applied pulse protocols (see Timin
and Hering, 1992).
Sequence environment of PAA receptor site
affects the apparent association and dissociation
rate constants of (-)devapamil
Our results revealed a substantial modulation of the PAA-
Ca2+ channel interaction by the sequence environment of
the putative receptor site. The apparent drug association
rates of mutant AL25 exceeded those of the L-type chimera
Lh by -5 times (Table 1). The same effect was evident from
the time courses of block development in Lh and AL25
shown in Fig. 1. Hence identical pulse protocols always
induced a faster block development in mutant AL25.
Apparent dissociation rates estimated from the current
decay during a given train of pulses (Table 1) slightly
exceeded those obtained from recovery measurements (Fig.
2). To a first approximation, we estimated an "averaged"
apparent dissociation rate from open and resting channels.
Consequently, dissociation rates estimated from pulse train
experiments will exceed the rate of recovery from block at
-80 mV holding potential where Ca2+ channels are exclu-
sively in a closed resting conformation (Table 1, Fig. 2). We
therefore conclude that PAA dissociation from open Ca21
channels might occur at significantly higher rates than from
a closed-channel conformation because of drug trapping.
Point mutations of the PAA receptor site affect
only the apparent association rate
of (-)devapamil
Previous attempts to estimate the impact of individual
amino acids on formation of the PAA receptor site in
165Degtiar et al.
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transmembrane segment IVS6 used the steady level of cur-
rent inhibition during a standard pulse train for character-
ization of the PAA sensitivity (Hockerman et al., 1995;
Doring et al., 1996; Hering et al., 1996). We confirmed the
validity of this approach by showing that a reduced sensi-
tivity for (-)devapamil of chimeras AL25/-Y, AL25/-A,
and AL25/-I was accompanied by a reduction in channel
block during pulse trains compared to AL25 (Table 3).
More detailed information can be obtained from an esti-
mation of the apparent drug association rates (Fig. 3, B and
C). As expected from previous experiments with gallopamil
(Hering et al., 1996), single point mutations of the PAA
receptor site in AL25 reduced PAA association rates. Com-
pared to AL25, mutants AL25/-Y and AL25/-A had an
approximately threefold reduced apparent (-)devapamil as-
sociation rate. Interestingly, a -30-fold reduction was ob-
served for mutant AL25/-I, suggesting a key role for Ile-
1811 in AL25 (corresponding to Ile- 1470 in alc-c;
Hockerman et al., 1995) in the formation of the PAA
receptor site.
Surprisingly, the recovery of IBa from block at rest
(Fig. 6) as well as the apparent dissociation rate constants
estimated from train experiments (Table 3) were not signif-
icantly affected by point mutations of the putative PAA
receptor site (chimeras AL25/-Y, AL25/-A, and AL25/-I).
As mentioned above, we cannot exclude the possibility that
drug dissociation from closed channels occurs at a signifi-
cantly slower rate than from open channels. We assume that
drug dissociation from the PAA receptor site in the channel
pore is not rate limiting for channel unblock at rest. "Guard-
ing" channel structures (Hille, 1977; Starmer and Grant,
1985), preventing drug access to the receptor site in closed
channels, may also prevent drug escape from the channel
pore in the resting state (see Qu et al., 1995, for analogous
structures in sodium channels). If this energy barrier is
higher than the energy required for drug dissociation from
the receptor site, the resulting dissociation rate at rest would
not significantly depend on the determinants of the putative
receptor site.
We have shown that PAA association as well as dissoci-
ation are strongly affected by the sequence environment of
the putative receptor site. Those structural elements could
directly contribute binding energy for the PAA-receptor
interaction, modulate the access pathway of PAAs to their
receptor site, or even participate in both processes. Further
progress in understanding of the molecular mechanisms of
PAA interaction with Ca2+ channels may therefore be ex-
pected from the development of new approaches that ac-
count for individual drug dissociation rates from open and
resting Ca2+ channels and the identification of drug access-
regulating, "guarding" amino acids.
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